We are live on
!
Find out more
Iovance Biotherapeutics
IOVA
IOVA
82 hedge funds and large institutions have $271M invested in Iovance Biotherapeutics in 2015 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
2,871% more call options, than puts
Call options by funds: $6.39M | Put options by funds: $215K
37% more capital invested
Capital invested by funds: $198M → $271M (+$73.8M)
26% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 23
14% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 14
3% more funds holding
Funds holding: 80 → 82 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
82
Holders Change
+2
Holders Change %
+2.5%
% of All Funds
2.15%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
16
Increased
29
Reduced
23
Closed
14
Calls
$6.39M
Puts
$215K
Net Calls
+$6.17M
Net Calls Change
+$6.21M
Top Buyers
Top Sellers
| 1 |
Citigroup
New York
|
-$2.46M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$2.03M |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$1.73M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$1.26M |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$750K |
